Pishvaian MJ, Lee MS, Ryoo B, et al. Updated safety and clinical activity results from a Phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC). ESMO 2018, abstract LBA26.
Klinisch bewijs binnen handbereik met behulp van AI
mei 2024 | Gynaecologische oncologie, Longoncologie, Maag-darm-leveroncologie, Uro-oncologie